Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue-Beneficial Effects on Self-Assessment Scales But Not on Molecular Markers.
- DOI
- 10.3390/biom11030393
- Published
- 2021 Mar 7
- Container
- Biomolecules
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/biom11030393,
title = {Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue-Beneficial Effects on Self-Assessment Scales But Not on Molecular Markers.},
author = {Neuhaus O and Köhler W and Then Bergh F and Kristoferitsch W and Faiss J and Rosenkranz T and Reske D and Patejdl R and Hartung HP and Zettl UK},
year = {2021},
journal = {Biomolecules},
doi = {10.3390/biom11030393},
url = {https://doi.org/10.3390/biom11030393}
}RIS
TY - JOUR TI - Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue-Beneficial Effects on Self-Assessment Scales But Not on Molecular Markers. AU - Neuhaus O AU - Köhler W AU - Then Bergh F AU - Kristoferitsch W AU - Faiss J AU - Rosenkranz T AU - Reske D AU - Patejdl R AU - Hartung HP AU - Zettl UK PY - 2021 JO - Biomolecules DO - 10.3390/biom11030393 UR - https://doi.org/10.3390/biom11030393 ER -
APA
O, N., W, K., F, T. B., W, K., J, F., T, R., D, R., R, P., HP, H., & UK, Z. (2021). Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue-Beneficial Effects on Self-Assessment Scales But Not on Molecular Markers.. Biomolecules. https://doi.org/10.3390/biom11030393
Source records
- pubmed · retrieved 2026-09-27T01:23:46.735Z